StockData
Advanced Biomed Inc. logo

Advanced Biomed Inc. (ADVB) stock

ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.75−0.40 (-18.79%)

Close on Nov 19, 2026Market cap $2.89MP/E 0.3Yield –

Advanced Biomed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Advanced Biomed's free cash flow for the twelve months ending Mar 31, 2026 was -$2.94M. For fiscal 2025 it was -$5.86M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Jun 30, 2025-$5.86M–
FY2024Jun 30, 2024-$2.20M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ1 2026Mar 31, 2026-$241.04K–
Q2 FY2026CQ4 2025Dec 31, 2025-$526.46K–
Q1 FY2026CQ3 2025Sep 30, 2025-$612.11K–
Q4 FY2025CQ2 2025Jun 30, 2025-$1.56M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.41M–
Q2 FY2025CQ4 2024Dec 31, 2024-$831.15K–
Q1 FY2025CQ3 2024Sep 30, 2024-$49.66K–
Q4 FY2024CQ2 2024Jun 30, 2024-$529.08K–
Q3 FY2024CQ1 2024Mar 31, 2024-$1.04M–

More Advanced Biomed figures

See a number that looks wrong?